Which has grown faster, ATRC or DNLI?

Over the past five years, DNLI grew revenue faster — ATRC at a 18.57% CAGR versus DNLI at 20.68%.

Is ATRC or DNLI more profitable?

ATRC runs the higher net margin — ATRC at 1.85% versus DNLI at -14191.20%.

How have ATRC and DNLI total returns compared?

Over the past 5 years, ATRC delivered -4.06% and DNLI delivered -16.91% annualized total return. Past performance doesn't predict future results.

AtriCure, Inc. (ATRC) vs Denali Therapeutics Inc. (DNLI)

A side-by-side comparison of AtriCure, Inc. and Denali Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATRC

AtriCure, Inc.

$2.73B

$53.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

DNLI

Denali Therapeutics Inc.

$3.06B

$19.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ATRC vs DNLI

growth of $100 · dividends reinvested · last 9y

ATRC +213.9% (+13.6%/yr)DNLI -7.2% (-0.8%/yr)ATRC compounded faster over this window

ATRC DNLI

ATRC vs DNLI: by the numbers

•DNLI is the larger company ($3.06B vs $2.73B market cap).
•ATRC is profitable (1.85% net margin) while DNLI runs a net loss (-14191.20%).
•DNLI grew revenue faster over the past five years (20.68% vs 18.57% CAGR).

Metrics side by side

Valuation

Metric	ATRC	DNLI
P/E ratio	252.97	N/A
P/S ratio	4.79	849.04
P/B ratio	5.29	3.66
EV / EBITDA	75.80	N/A
FCF yield	1.88%	N/A

Profitability

Metric	ATRC	DNLI
Gross margin	76.16%	0.00%
Operating margin	2.44%	0.00%
Net margin	1.85%	-14191.20%
ROE	2.04%	-61.24%
ROIC	2.04%	-50.82%

Growth (annualized)

Metric	ATRC	DNLI
Revenue CAGR (5Y)	18.57%	20.68%
Total return CAGR (5Y)	-4.06%	-16.91%

Frequently asked

Which has grown faster, ATRC or DNLI?: Over the past five years, DNLI grew revenue faster — ATRC at a 18.57% CAGR versus DNLI at 20.68%.
Is ATRC or DNLI more profitable?: ATRC runs the higher net margin — ATRC at 1.85% versus DNLI at -14191.20%.
How have ATRC and DNLI total returns compared?: Over the past 5 years, ATRC delivered -4.06% and DNLI delivered -16.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ATRC analysis Full DNLI analysis Interactive comparison tool

Dig into the metrics

AtriCure P/E ratio AtriCure ROE Denali Therapeutics ROE AtriCure operating margin Denali Therapeutics operating margin AtriCure revenue growth Denali Therapeutics revenue growth AtriCure free cash flow Denali Therapeutics free cash flow

AtriCure & Denali Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.